10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $492,068 | -98.0% | 8,820 | -97.3% | 0.00% | -96.2% |
| Q1 2022 | $24,994,000 | +109.7% | 328,561 | +310.6% | 0.08% | +166.7% |
| Q4 2021 | $11,920,000 | -47.5% | 80,024 | -48.7% | 0.03% | -44.4% |
| Q3 2021 | $22,717,000 | -16.8% | 156,047 | +11.9% | 0.05% | -15.6% |
| Q2 2021 | $27,305,000 | -9.8% | 139,437 | -16.7% | 0.06% | -19.0% |
| Q1 2021 | $30,283,000 | +253.0% | 167,312 | +176.2% | 0.08% | +259.1% |
| Q4 2020 | $8,579,000 | +105.1% | 60,584 | +80.6% | 0.02% | +83.3% |
| Q3 2020 | $4,182,000 | +91.7% | 33,538 | +37.4% | 0.01% | +71.4% |
| Q2 2020 | $2,181,000 | -52.0% | 24,415 | -66.5% | 0.01% | -30.0% |
| Q1 2020 | $4,540,000 | +71.6% | 72,834 | +109.9% | 0.01% | 0.0% |
| Q4 2019 | $2,646,000 | +776.2% | 34,703 | +478.4% | 0.01% | +900.0% |
| Q3 2019 | $302,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |